Skip to main content
Premium Trial:

Request an Annual Quote

Proteome Sciences, Sigma-Aldrich Reach Deal to Sell ProteoPrep Products


Proteome Sciences this week entered into a non-exclusive licensing deal allowing Sigma-Aldrich to continue selling products under the ProteoPrep name in Europe, Japan, and Australia.

Sigma-Aldrich has been selling immunodepletion kits under ProteoPrep name, which is a trademark registered to Proteome Sciences in the three geographies covered by this week's announcement.

Currently, Sigma-Aldrich sells 11 ProteoPrep kits. The license includes those products and all future products containing chemicals and reagents for disrupting cells, tissues, or other biological material, and the extraction of biological molecules such as proteins, lipids, and carbohydrates.

The deal also covers methods and processes related to assays for diagnosing disease, as well as chemical markers for determining proteins and peptides by disruption of cells, tissues, and other biological materials, and for targeting drugs.

Proteome Sciences received a signing fee and will receive royalties on product sales. Other financial terms of the deal were not disclosed.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.